Studies have shown that there is a negative correlation between the serum albumin level of MM patients and the expression of IL-6, which is related to the abnormal proliferation of myeloma cells, so the serum albumin level can be used as an important serological marker to evaluate the tumor load of MM (33). Here, IL6 is linked to plasma cell myeloma.